OWKIN
7 known investors
Owkin develops AI Scientist, an autonomous AI system that uses biological large language models and multimodal patient data to accelerate drug discovery for pharmaceutical and biotech companies. The company aims to automate early-stage R&D and compress decades of discovery timelines into years.
Investors · 7
Bridford Investments (Bridford Group)London
Cathay InnovationParis · $5M – $40Mvia Jacky Abitbol · led
F-Prime Capital PartnersCambridge · $3M – $10M
GV (Google Ventures)Mountain View · $250K – $50M
Alpha Intelligence CapitalreportedSan Francisco
FrstreportedParis · $540K – $5.4M
OTB VenturesreportedAmsterdam · $1.1M – $7.7M
In the news
- Owkin Secures $33.0M Investment | Signalbasetrysignalbase.com · 2026
- Owkin spinout Waiv raises $33m to scale AI-powered medical testingsifted.eu · 2026
- Sell or Invest in Owkin Stock Pre-IPOnasdaqprivatemarket.com · 2024
- Owkin becomes ‘unicorn’ with $180m investment from Sanofi - Owkinowkin.com · 2021
- Owkin Raises $25M to Enhance Medical Research Machine Learning and Collaboration – AlleyWatchalleywatch.com · 2020